1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Compensatory Hyperinsulinemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeFronzo, RA; Haywood, JR; Koopmans, SJ; Kudolo, GB | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Chronic hyperinsulinemia inhibits platelet-activating factor (PAF) biosynthesis in the rat kidney.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Animals; Blood Pressure; Chronic Disease; Hyperinsulinism; Insulin; Insulin Resistance; Kidney; Male; Phospholipases A; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 1997 |